Instructions for Nazol Advance (Oxymetazoline) Spray nasal 10 ml
English Product Name
Nazol Advance
Release Form
nasal spray 0.05%: fl. 15 ml or 30 ml with spraying device
Description Nazol Advance
Spray nasal 0.05% in the form of clear liquid from colorless to light yellow, with a faint smell of menthol, eucalyptus and camphor.
100 ml
oxymetazoline hydrochloride 0.05 g
Auxiliary substances: benzalkonium chloride - 0.02 g, racemic camphor - 0.17 g, eucalyptol (cyneol) - 0.17 g, levomenthol - 0.17 g, ethanol dinatry dihydrate - 0.1 g, polysorbate 80 - 0.2 g, propylene glycol - 10 g, sodium hydrophosphate dihydrate - 0.006 g, sodium dihydrophosphate dihydrate - 0.65 g, hydrochloric acid c. - 0.003 g, purified water - 89.711 g
15 ml - polyethylene bottles (1) with a spraying device - cardboard packs.
30 ml - polyethylene bottles (1) with a spraying device - cardboard packs.
ATX codes
R01AA05 Oxymetazoline
Clinical and pharmacological groups / Group affiliation
Topical decongestant ENT therapy
Active ingredient
oxymetazoline hydrochloride
Pharmacotherapeutic group Nazol Advance
Anti-congestive agent in the form of vasoconstrictor (alpha-adrenomytic)
Retention conditions
Store the drug in a dry, out-of-reach setting for children, at temperatures ranging from 2° to 25° C.
Expiration date
Shelf life - 2 years.
Pharmacological effect Nazol Advance
Oxymetazoline is a topical vasoconstrictor drug for ENT applications.
This drug, which is part of the group of alpha-adrenomymetics, has a vasoconstricting effect. Through intranasal administration, it is able to reduce swelling of the mucosa of the upper respiratory tract, which facilitates nasal respiration and improves the patency of the sinuses and eustachian tubes. Positive results appear 10 to 15 minutes after use and persist for 10 to 12 hours.
Indications Nazol Advance
This drug is recommended to be used in cases of runny nose, cold and viral infections of the upper respiratory tract, as well as sinusitis and rhinitis, regardless of their causes.
Method of administration and dosage
Adults and children older than 12 years are advised to use 2-3 injections in each nasal passage twice a day. Children age 6 to 12 years (monitored by adults) should have one injection in each nasal passage 2 times a day. The use of the drug is not recommended more than 2 times a day.
The drug should not be used for more than 3 days. Continuous or prolonged use of the drug can lead to repeated or increased nasal breathing difficulties. If such symptoms occur, stopping treatment and seeking medical help is recommended.
Do not throw the head back or spray the drug while lying down while injecting.
- Nosology (ICD codes)
- J00
- Acute nasopharyngitis (runny nose)
- J01
- Acute sinusitis
- J31
- Chronic rhinitis, nasopharyngitis, and pharyngitis
- J32
- Chronic sinusitis
